REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanofarma Development OOO (Нанофарма Девелопмент ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Nanofarma Development OOO Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Nanofarma Development OOO (Нанофарма Девелопмент ООО) is based in Russia, with the head office in Kazan. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on December 31, 2013. In 2024, the company reported a net sales revenue increase of 6.47%. Over the same period, its total assets grew by 53.54%. The enterprise’s net profit margin decreased by 10.29% in 2024.

Headquarters
Vosstaniya, 102V
Kazan; Tatarstan Republic; Postal Code: 420095

Contact Details: Purchase the Nanofarma Development OOO (Нанофарма Девелопмент ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Nanofarma Development OOO (Нанофарма Девелопмент ООО) report to view the information.
Financial Auditors:
Purchase the Nanofarma Development OOO (Нанофарма Девелопмент ООО) report to view the information.
Incorporation Date:
December 31, 2013
Key Executives
Purchase this report to view the information.
General Director
Subsidiaries
Sever OOO
1%
Company Performance
Financial values in the chart are available after Nanofarma Development OOO (Нанофарма Девелопмент ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
6.47%
Total operating revenue
6.47%
Operating profit (EBIT)
-28.51%
Net Profit (Loss) for the Period
-61.3%
Total Assets
53.54%
Total Equity
15.1%
Operating Profit Margin (ROS)
-11.51%
Net Profit Margin
-10.29%
Return on Equity (ROE)
-25.9%
Debt/Equity
33.51%
Quick Ratio
-0.83%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?